Skip to content

Quick Structured Clinical Interview for DSM-5® Disorders (QuickSCID-5)

Michael B. First, M.D., and Janet B. W. Williams, Ph.D.

  • 2021
  • 61 Pages
  • ISBN 978-1-61537-363-5
  • Item #37363

View Pricing

List Price

APA Members

20% off

APA Resident-Fellow Members

25% off

Buying In Canada or Europe?


QuickSCID-5 is a fully structured diagnostic instrument that employs interview questions adapted from the Structured Clinical Interview for DSM-5 (SCID-5), widely regarded to be the gold standard structured psychiatric diagnostic interview since the initial release of SCID in 1985. The impetus for developing the QuickSCID-5 was to create a briefer, more time-efficient version of the SCID designed to be administered usually in 30 minutes or less. The shorter administration time results from the fact that QuickSCID-5 consists almost entirely of closed-ended questions that can be answered YES or NO by the patient, dispensing with the requirement in the standard SCID that the interviewer elicit descriptive examples and ask enough follow-up questions until the interviewer has enough information to determine whether the DSM-5 diagnostic criteria are met. Consequently, unlike the standard SCID, which requires the interviewer to have specialized training in diagnostic interviewing, QuickSCID can be administered by any clinician, including those in training. Other features include a visually appealing format and easy to follow skip instructions.

QuickSCID has a modular design so that only modules of interest need be administered. Modules include an optional Overview, Module A (Mood Episodes and Disorders), Module B (Psychotic Symptoms Screen), Module C (Alcohol and Other Substance Use Disorders), Module D (Anxiety Disorders), Module E (Obsessive-Compulsive Disorder); Module F (Adult Attention-Deficit/Hyperactivity Disorder), Module G (Posttraumatic Stress Disorder), Module H (Eating Disorders), Module I (Screening for Other Disorders), and Module J (Rule Out Mental Disorders Due to a Medical Condition and Substance/Medication-induced Mental Disorders). In recognition of the fact that it is not recommended to make a diagnosis of a psychotic disorder such as schizophrenia using questions that can only be answered YES or NO, QuickSCID-5 only screens for psychotic symptoms and is not intended to be used to diagnose psychotic disorders. These diagnoses are not included in QuickSCID-5.

Although the absence of a requirement for the interviewer to elicit descriptive examples may lead to more false positives than the standard SCID, the savings in administration time and its allowance for it to be administered by less trained interviewers can constitute a reasonable trade-off depending on the setting (e.g., for screening patients for the presence of a mental disorder).

Purchase includes a license to photocopy for private clinical assessment use, up to 200 total copies per customer.


  • QuickSCID-5 Diagnostic Summary
  • QuickSCID-5 Instructions
  • Overview
  • Module A. Mood Episodes and Disorders
  • Module B. Psychotic Symptom Screen
  • Module C. Alcohol and Other Substance Use Disorders
  • Module D. Anxiety Disorders
  • Module E. Obsessive-Compulsive Disorder
  • Module F. Adult Attention-Deficit/Hyperactivity Disorder
  • Module G. Posttraumatic Stress Disorder
  • Module H. Eating Disorders
  • Module I. Screening for Other Disorders
  • Module J. Rule Out Mental Disorders Due to Another Medical Condition and/or Substance/Medication-Induced Disorders

About the Authors

Michael B. First, M.D., is Professor of Clinical Psychiatry at Columbia University, and Research Psychiatrist in the Division of Behavioral Health Services and Policy Research Diagnosis and Assessment Lab at New York State Psychiatric Institute in New York, New York.

Janet B. W. Williams, Ph.D.,
is Professor Emerita of Clinical Psychiatric Social Work (in Psychiatry and Neurology) at Columbia University, and Research Scientist and Deputy Chief of the Biometrics Research Department (Retired) at New York State Psychiatric Institute in New York, New York; and Senior Vice President of Global Science (Retired) at MedAvante Inc. in Hamilton, New Jersey.

Related Products

Become an APA Member
Join Now